전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved4 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#Popular#monoclonal-antibody+1
Trials 60Status Active
AntibodyLimited DatastaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

OPTIMOX-bevacizumab (OPTIMOX-bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab + metronomic chemotherapy)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active